Nipro Corporation (FRA:5FA)

Germany · Delayed Price · Currency is EUR

7.85

-0.20 (-2.48%)

At close: Sep 18, 2026

Market Cap	1.33B -7.9%
Revenue (ttm)	3.60B +2.7%
Net Income	75.78M +144.4%
EPS	0.41 +145.3%
Shares Out	n/a
PE Ratio	17.58
Forward PE	n/a
Dividend	0.17 (2.16%)
Ex-Dividend Date	Sep 29, 2026

Volume	n/a
Open	7.85
Previous Close	8.05
Day's Range	7.80 - 7.85
52-Week Range	7.50 - 9.25
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 10, 2026

About Nipro

Nipro Corporation, together with its subsidiaries, engages in the medical devices, pharmaceuticals, and pharma packaging businesses worldwide. The company offers renal products; interventional products, such as cardiovascular products, endovascular products, and accessories; and hospital products, including hypodermic needles, syringes, IV sets and catheters, 3-way stopcocks, infusion sets, balloon infusers, etc. It also provides cardiopulmonary products comprising oxygenators, cardioplegia heat exchangers, perfusion tubing sets, arterial filte... [Read more]

Industry Orthopedic, Prosthetic, and Surgical Appliances and Supplies

Founded 1947

Employees 38,593

Stock Exchange Frankfurt Stock Exchange

Ticker Symbol 5FA

Financial Performance

In fiscal year 2026, Nipro's revenue was 660.54 billion, an increase of 2.47% compared to the previous year's 644.59 billion. Earnings were 13.50 billion, an increase of 164.11%.

Financial numbers in JPY Financial Statements